The aim of our study was to investigate the possible role of functional polymorphisms of antioxidant enzymes SOD2 and GPX1 and regulatory antioxidant protein Nrf2, alone or combined, in susceptibility to prostate cancer development and overall survival in Serbian male patients. This evidence concerns the gene SOD2 and prostate carcinoma.